abstract: Success rate in human pregnancies is believed to be very low and sex-specific mechanisms may operate in prenatal loss.
Introduction
Prenatal loss is a common occurrence. The survival probability of human conceptions from fertilization to term is estimated to be ,25% (Roberts and Lowe, 1975; Drife, 1983; Boklage, 1990) . There are currently no reliable genetic polymorphisms recognized as markers for prenatal selection. Preimplantation genetic screening (PGS) or diagnosis (PGD) panels do not contain a polymorphic marker to predict the survival probability of embryos (Braude, 2006; Sierra and Stephenson 2006; Geraedts and De Wert, 2009) . In vitro fertilization (IVF) clinics use PGS mainly to screen for chromosomal aneuploidy and when indicated, PGD is performed to screen for chromosomal rearrangements and monogenic disease mutations (Geraedts and De Wert, 2009) . Given the high failure rate in natural pregnancies and in assisted reproductive technologies, there is a need for genetic markers predicting the probability of pregnancy success.
There are some suggestions that a sex-differential exists in prenatal selection. Earlier studies reviewed existing data from induced and spontaneous miscarriages and concluded that the male-to-female ratio was very high for early in utero loss and the earlier in the pregnancy the higher the ratio (Shettles, 1961; Stevenson and Bobrow, 1967; Lee and Takano, 1970; Kellokumpu-Lehtinen and Pelliniemi, 1984) . The sexing methods of those times were not accurate and those estimates might have been biased towards male sexing. More recent studies of aborted fetuses that corrected for maternal contaminants, 46,XX hydatidiform moles of androgenetic origin and used cytogenetics for sex determination showed a male-to-female ratio of 130:100 in anatomically (Byrne and Warburton, 1987) and cytogenetically (Hassold et al., 1983) normal fetuses. Large population-based studies of preterm birth have also shown increased male-to-female ratio in very early preterm births or stillbirths (McGregor et al., 1992; Smith, 2000; Ingemarsson, 2003; Zeitlin et al., 2004; Vatten and Skjaerven, 2004; Jongbloet, 2005) . For example, in the populationbased Norwegian study, the sex ratio for very early (16-19 weeks) preterm births was 248 males to 100 females (Vatten and Skjaerven, 2004) . Thus, prenatal selection may act differentially on males and females. Emerging data from prenatal genetic diagnosis laboratories, however, do not suggest a sex-differential in embryos produced by assisted reproductive technologies. These observations urge more carefully designed research for firm conclusions.
Most genetic association studies on prenatal selection focused on recognized repeated pregnancy losses, which constitute a minority of all pregnancy losses (Boklage, 1990; Brown, 2008) and such studies cannot address the sex effect. We reasoned that by examining genotype frequencies in healthy babies born at term, we can elucidate the genetic loci that may influence sex-specific prenatal loss. According to laws of genetics (Hardy-Weinberg principles and Mendelian laws), genotype frequencies of autosomal polymorphisms should be similar in males and females. Any difference observed may thus be due to prenatal selection among other alternative explanations. We have already reported observations on sex-specific genotype differences in HLA and natural killer cell membrane protein NKG2D (formally KLRK1) region polymorphisms (Dorak et al., 2002; Ucisik-Akkaya and Dorak, 2009 ). Likewise, others also used the same approach to obtain clues regarding prenatal selection (Healey et al., 2000; Teare et al., 2004) . In the present study, we extended those initial studies to a large number of candidate markers. The candidate gene selection was guided by knowledge of genes involved in human reproductive failure (Choudhury and Knapp 2001a,b; ESHRE Capri Workshop Group, 2008) as well as previously reported associations with infertility, implantation failure and repeated pregnancy loss (Choudhury and Knapp, 2001b; Denschlag et al., 2004; Saijo et al., 2004; Kay et al., 2006; Bombell and McGuire, 2008; Choi and Kwak-Kim, 2008; Cochery-Nouvellon et al., 2009; Kang et al., 2009) . Given the recently reported correlations between iron-regulatory gene polymorphisms and fetal growth with sex-specificity , we also included a number of iron-regulatory gene variants. In this exploratory study, 333 single nucleotide polymorphisms (SNPs) from 107 candidate genes were genotyped in newborns and genotype frequencies were compared between male and female newborns. Any difference between the frequencies was considered to be a provisional indication of possible differential viability of male and female offspring bearing that genotype.
Materials and Methods

Sample
The population sample analyzed in this study consisted of 388 umbilical cord blood samples (201 girls and 187 boys) from South Wales (UK). Blood samples were anonymously obtained from consecutively born fullterm babies born at two South Wales (UK) Hospitals during 1996 -1998. Only singleton babies born via vaginal delivery were included.
Although not recorded individually, a great majority of babies are expected to have European ancestry. The South Wales Research Ethics Committee (UK) approved the use of these samples for genetic research. We previously reported sex-differentials in HLA class II region and NKG2D (formally KLRK1) genotype frequencies in the same set of newborns (Dorak et al., 2002; Ucisik-Akkaya and Dorak, 2009) . Three hundred and eighty-eight of the originally collected 414 samples were genotyped due to limited DNA availability.
SNP selection
Using a candidate gene approach, we selected SNPs and other polymorphisms to examine their frequencies in male and female newborns. Biologically plausible candidate genes were selected based on combined knowledge of their involvement in pregnancy loss (Choudhury and Knapp, 2001b; Bombell and McGuire, 2008; Choi and Kwak-Kim, 2008) , sex-differential effects (Escobar-Morreale et al., 2001; Dorak et al., 2002; Villuendas et al., 2002; Kantarci et al., 2008) and relevant physiologic traits encoded by HLA complex genes (DNA repair, apoptosis, transcriptional machinery; Horton et al., 2004) . Most markers were from the HLA complex and ironregulatory genes and also included selected cytokine genes. We specifically included polymorphisms from genes that are associated with implantation failure such as TP53 (Kay et al., 2006; Kang et al., 2009 ) and repeated pregnancy loss [HMOX1 (Denschlag et al., 2004) , IL6 (Saijo et al., 2004; Bombell and McGuire, 2008) , IL10 (Cochery-Nouvellon et al., 2009), IL1B (Bombell and McGuire, 2008) ]. The final SNP list included 333 polymorphisms (327 autosomal and 6 X-linked; Supplementary data, Table S1 ). The table provides the gene name, the SNP ID number as listed in National Center for Biotechnology Information (NCBI) Entrez SNP, chromosomal location and the position in the chromosome as nucleotide number beginning from the telomere of the short arm.
Genotypings
We aimed to genotype all SNPs by TaqMan analysis. TaqMan allelic discrimination assays were performed on the Stratagene Mx3000P instruments. The standard thermal profile protocol was used [15 s at 958C (denaturation) and 90 s at 608C (annealing and extension) for 40 cycles]. Validated TaqMan w SNP genotyping assays were purchased from Applied Biosystems (ABI, Foster City, CA, USA). ABI does not provide primer and probe sequences. Each plate contained intra-and inter-plate controls and no-template controls. Stratagene Mx3000P software was used to assign genotypes.
When TaqMan genotyping assays were not successful; we used alternative methods such as PCR-RFLP (for example, HSPA1B rs1061581, HLA-DQA1 rs1142316, MICA rs1051792 and MDM2 rs2279744), high-resolution melting analysis (HLA-DRA rs3135388 and HMOX1 rs5755709) or direct size determination on agarose gel (HLA-G rs1704 indel polymorphism). 
Statistical analysis
Statistical analysis of genotype frequencies was carried out on Stata Statistical Software Release 10.0 (StataCorp LP, College Station, TX, USA). We obtained the odds ratio (OR) and its 95% confidence interval (CI) as the measure of association strength and P-values for statistical significance by logistic regression (command 'logistic'). The statistical analysis included allele frequency comparisons, and examination of genetic models (additive, dominant, recessive and dominance) for genotype frequency differences between male and female newborns. We coded males as cases and females as controls. Thus, ORs below 1.0 denote lower frequencies in males and ORs above 1.0 indicate higher frequencies in males. The X chromosome gene HEPH SNPs were only examined for allele frequency differences between males and females.
We also used genotype-based population genetics methods to search evidence for selection by Hardy -Weinberg equilibrium (HWE) and Ewens-Watterson (E -W) tests (Rousset and Raymond, 1997) although Genetic markers for sex-specific prenatal selection the E-W test has low statistical power (Zhai et al., 2009) . The E -W test was used only as a confirmatory test in the presence of any frequency difference between males and females. HWE was assessed on Stata (command 'genhwcci') and E -W test was performed on PopGene version 1.32 (http://www.ualberta.ca/~fyeh). The final set of SNPs was selected as the most meaningful markers because of their consistent associations by above methods. This set consisted of independent SNPs as confirmed by multivariable logistic regression. These SNPs were also assessed by the permutation test on Stata (command 'permute') to eliminate false-positives due to multiple comparisons (McIntyre et al., 2000) .
Since many polymorphisms were genotyped, we had to consider false-positives. In the absence of bias, the probability that a statistically significant finding is actually a false-positive finding is determined by the magnitude of the P-value, the statistical power and the probability of a meaningful association between the genetic variant and the response, hereafter called the prior probability (Wacholder et al., 2004) . One index that summarizes all of these parameters is the false-positive report probability (FPRP) value. Rather than using the unpopular Bonferroni correction which does not take into account the statistical power and punishes smaller studies that do not have very high statistical power, we present the FPRP values for each association.
Results
Univariable analysis
A total of 333 SNPs were genotyped in 388 (201 girls and 187 boys) full-term newborns born via vaginal delivery. We first examined Hardy-Weinberg genotype distributions for the concordance between observed and expected frequencies. Violation of HWE suggests either selection as one of the biological explanations or genotyping error. In the whole sample, HWE test showed only few deviations. We excluded such SNPs from further analyses unless Hardy-Weinberg disequilibrium was exclusive to one sex only, which was taken as an indication of sex-specific selection.
HWE was violated in the NKG2D region SNP rs10772266 (P ¼ 0.004) but in sex-specific analysis, this distortion was evident in males only (P ¼ 0.02) suggesting a selection event affecting males during prenatal period. The results of 10 SNPs analyzed in this region were described elsewhere (Ucisik-Akkaya and ). In some other SNPs, there was HWE violation in the overall newborn group but in the sex-specific analysis, it was exclusive to one sex (see for example, GTF2H4, IL6 and HMOX1 in Table I ).
In the analysis after stratification by sex, 14 SNPs showed differences in genotype frequencies between males and females individually with an additional eight SNPs contributing to three multi-SNP markers (Tables I  and II) . When genotypes bearing the variant alleles were used (variant allele positivity/dominant model or variant allele homozygosity/recessive model), not all differences were deficiencies in males. Some comparisons did not reach statistical significance using the conventional criterion (P ≤ 0.05) but if the association was marginally significant (P ¼ 0.06-0.10) and OR ≤ 0.67, they were retained for further analyses.
Among the extended HLA complex SNPs, RXRB (retinoid X receptor beta) rs421446, RXRB rs2076310, BRD2 (bromodomain containing 2) rs635688, GTF2H4 (general transcription factor IIH polypeptide 4) rs3909130, HIST1H1T (histone cluster 1 H1T) rs198844 and HLA-E rs1264456 showed genotype frequency differences between males and females ( Table I ). The first three SNPs are from adjacent genes and multivariable logistic regression showed that RXRB rs2076310 was the independent one.
Among the immune system gene polymorphisms examined, two SNPs in cytokine genes, IFNG (interferon-gamma) rs2069727 and IL6 (interleukin-6) rs1800796, showed different genotype frequencies showed the strongest association: variant allele frequencies were different between males and females (P ¼ 0.02) and homozygosity rates for the variant allele were also different (P ¼ 0.04; Tables I  and II) along with the gene-dosage effect (see below). SLC11A2 (NRAMP2, natural resistance-associated macrophage protein 2) rs422982, SLC40A1 (ferroportin) rs1439814, TMPRSS6 (transmembrane serine protease 6) rs733655, HMOX1 (heme oxygenase 1) rs2071748 and RRM2 (ribonucleotide reductase M2 polypeptide) rs1130609 showed genotype frequency differences between male and female newborns (dominant or recessive genetic model) among the iron-regulatory gene SNPs examined.
Associations of multiple SNPs jointly in the absence of individual associations
Individually LIF (leukemia inhibitory factor), TP53 (tumor protein 53) and its regulator MDM2 SNPs did not show a statistically significant association with sex-specific prenatal loss. The only suggestive association was with wildtype homozygosity for the LIF SNP rs929271, which yielded an OR of 0.71 (P ¼ 0.10). LIF is known to interact with TP53 and MDM2 in implantation failure (Kang et al., 2009) . The combination of having wildtype homozygote genotypes in the three SNPs at LIF (rs929271), TP53 (rs1042522) and MDM2 (rs2279744/SNP309) showed a deficit in newborn males compared with females (6.77% in males versus 12.8% in females, P ¼ 0.05).
The three SNPs from the HLA complex (HLA-DQA1 rs1142316, HLA-DRA rs7192 and HSPA1B rs1061581) characterize the major HLA class II region lineages (Dorak et al., 2006) . In the present study, combined homozygosity for ancestral lineages showed a decreased frequency in male newborns compared with the corresponding rate in female newborns (5.85% in males versus 13.9% in females, P ¼ 0.006). The combinations that gave rise to this strong association were homozygosity for wildtype alleles at all three SNPs or variant alleles at all three SNPs. This finding was equivalent to the original results obtained by HLA typing (Dorak et al., 2002) .
Heterozygous genotypes of IRF4 (interferon regulatory factor 4) SNPs rs12203592 and rs872071 in combination showed reduced frequencies in male newborns compared with female newborns (10.1% in males versus 19.4% in females, P ¼ 0.01). Genetic markers for sex-specific prenatal selection
Gene-dosage effect analysis
For SNPs that showed individual frequency differences in male versus female comparisons for dominant or recessive genetic models, we checked the gene-dosage effect (additive model; Lewis, 2002) . This analysis tests whether the association gets stronger with the increasing number of the variant allele. As shown in Table I , most SNPs showed a gene-dosage effect, a finding that adds further weight to plausibility of the association although in strictly dominant or recessive models associations, the additive model may not be statistically significant. In the case of heterozygote advantage (dominance) model, it is not expected to show statistical significance due to non-linearity of the changes in OR.
Ewens -Watterson test results
We, then, examined the SNPs that showed an association also for the signature of selection by Ewens-Watterson test. Four of the SNPs listed in Table I yielded statistically significant results indicative of selection: HIST1H1T rs198844 (overall and females), BRD2 rs635688 (females), KLRK1 rs10772266 (overall and males), IFNG rs2069727 (males). It was an interesting observation that these four SNPs yielded statistically significant results in four tests used (allele and genotype frequency differences, gene-dosage effect and E-W test). Only three other SNPs (two RXRB SNPs and the SLC11A2 SNP) yielded significant results in the three frequency-based tests but not in the E-W test. As mentioned above, the BRD2 and RXRB SNPs are in linkage disequilibrium.
False-positive report probabilities
The results of FPRP analysis are presented in Table II . We used the average of the ORs for all our associations as the OR that we had the power to detect as required for the calculation. The average OR was 0.56 (corresponding to 1.80 in the opposite direction).
Since there are subjective elements in determination of assumed parameters and interpretation, we used the FPRP values to rank the results from the least likely to the most likely to be false-positive. The top 10 markers ranked by their FPRP values were RXRB rs2076310, HIST1H1T rs198844, IRF4 heterozygosity, SLC40A1 rs1439814, HLA complex haplotype homozygosity, RXRB rs421446, SLC11A2 rs422982, HLA-E rs1264456 heterozygosity, KLRK1 rs10772266, IFNG rs2079727 (Table II) . Thus, three of the four markers (HIST1H1T rs198844, KLRK1 rs10772266, IFNG rs2069727) that yielded consistently positive results in the previous steps of analyses achieved better FPRP assessment than the rest of the markers.
Multivariable analysis
We have evaluated the independence of the markers ranked as the top 10 by FPRP values by multivariable logistic regression. This list included three of the four SNPs (HIST1H1T, KLRK1, IFNG SNPs) that yielded statistically most robust results by other criteria. The model that contained all 10 markers resulted in four of the markers losing statistical significance. The remaining six markers were independent of each other and provided a strong multimarker panel that showed statistically significant differences in their frequencies between male and female newborns (Table III) . When Monte Carlo permutation test was performed for the statistical significance of these markers that cannot be attributed to false-positives due to multiple comparisons, all six markers attained significance and the significance levels of associations were similar between the permutation test results and logistic regression results (Table III) . The six markers listed in Table III were altogether a relatively strong predictor of sex-specific prenatal selection as judged by the pseudo-R 2 value (0.087) obtained by multivariable logistic regression modeling. Individual markers, on the other hand, generally yielded pseudo-R 2 values ,0.01, the maximum being 0.013 (for the RXRB SNP).
In terms of sex-specificity, variant allele frequencies or genotype frequencies were lower in male newborns for RXRB and HIST1H1T SNPs and HSPA1B-DRA-DQA1 and IRF4 genotypes, whereas the variant allele frequencies were lower in female newborns for IFNG and KLRK1 SNPs. Thus, the final set of markers included potential predictors of sex-specific prenatal selection both for males and females.
Discussion
In the present study, we used a novel approach to test the hypothesis that prenatal selection has a sex-specific component. To generate preliminary data, we examined genetic markers in selected candidate genes in newborns and compared frequencies of genotypes between male and female newborns. We used each sex as the control group for the other for comparisons and also compared the results with expected frequencies. These comparisons yielded biologically plausible associations with sex-specific prenatal selection. The results of this exploratory study suggested that examination of genotype frequencies between male and female healthy full-term newborns may be used to select genetic polymorphisms for further testing to assess their value as genetic markers of reproductive success. Our approach of genotyping newborns to identify potential markers of prenatal selection is a novel one and has limitations as well as strengths. The major limitation is that it will only provide clues about fetal genotypes that are unfavorable for fetal development but will have limited power to identify maternal genotypes that are associated with infertility, implantation failure of immunologic rejection of fetus. On the other hand, since the end-products of successful pregnancies are examined, the results are a cumulative summary of all adverse events that may lead to any type of pregnancy failure. Ideally, these studies should also include parental genotypes for most meaningful results. Alternatively, a prospective design in fertility clinics using IVF and preimplantation genetic testing may provide informative results for associations between fetal/parental genotypes and embryo survival. Studies adopting our design can provide further candidate polymorphisms for inclusion in such studies. Our design was also unable to distinguish between pregnancy losses due to aneuploidy, the most common cause, from other causes. However, since no genetic markers are known to be associated with aneuploidy, it is unlikely that not being able to adjust for this information would have caused any bias. Any design that can exclude aneuploidy-related losses may actually increase statistical power to detect the markers for genetically mediated pregnancy losses.
Like most studies of multimarkers, ours also included a large number of candidate gene polymorphisms. We used a mixture of statistical techniques to obtain robust results that cannot be attributed to false-positives. Six of our markers showed consistent associations by multiple analytical methods including the Monte Carlo simulation (Table III) . Alternative explanations for our findings still include chance findings. Population stratification or selection bias are, however, unlikely since the differences were observed between male and female newborns from the same hospitals sampled at the same time period without any exclusion criteria.
We focused our efforts on selected candidate genes in biologically plausible targets. The first groups of genes were in the HLA complex. A total of 167 SNPs in 54 genes in the extended HLA complex were analyzed (Supplementary Table S1 ). The HLA complex was one of the first genetic regions implicated in reproductive failure (Lerner and Finch, 1991; Ober et al., 1992; Kostyu, 1994; Ober and van der Ven, 1997) . Initial studies used classical HLA antigens, but it is now known that there are embryo-expressed and evolutionarily conserved transcription factor genes within the HLA complex (Ziegler et al., 2005) that can be targeted directly. Of these, SNPs from RXRB and GTF2H4 showed statistically significant frequency differences between male and female newborns. Besides these, SNP genotypes from HLA-E and HIST1H1T encoded within the extended HLA class I region also showed frequency differences between males and females with HIST1H1T remaining in the final set. Although none of these SNPs have been examined in recurrent pregnancy loss (RPL) or prenatal selection by others, these are biologically plausible genes to mediate prenatal selection: RXRB is the receptor for the embryonic growth factor retinoic acid (Mangelsdorf et al., 1992; Wendling et al., 1999) , GTF2H4 is directly involved in both transcription and DNA repair mechanisms (Marinoni et al., 1997) , HLA-E is involved in materno-fetal immune interactions via regulation of natural killer cell activity (Tripathi et al., 2006) and histones play a role in chromatin formation, and specifically, HIST1H1T interacts with the HLA class II gene BRD2 (adjacent to RXRB) during embryonic development (Shang et al., 2009) . However, encouraging these observations may be, validity of our results can only be assured by replication and functional confirmation of the involvement of these polymorphisms in pregnancy failure.
Besides conventional cytokines, another cytokine LIF has emerged as an important regulator of implantation in the beginning of pregnancy (Hu et al., 2008) . There are also reports about its genetic associations with reproductive failure (Steck et al., 2004; Kang et al., 2009) . LIF interacts with TP53 and TP53 interacts with MDM2, its negative regulator (Kang et al., 2009) . Thus, functional polymorphisms of TP53 and MDM2 were also genotyped to examine any interaction and joint effects. We showed that combination of wildtype genotypes at three SNPs from LIF, TP53 and MDM2 (rs929271, rs1042522, rs2279744) was underrepresented in newborn males (Table II) . This finding suggested the involvement of LIF in reproductive success in interaction with TP53/MDM2 as has already been reported (Hu et al., 2008; Kang et al., 2009 ). The present investigation showed the sex-specificity of this effect in that having the wildtype homozygote genotypes at these three SNPs has a deleterious effect for male offspring and such offspring have two-times reduced chance of reaching the end of pregnancy compared with female offspring.
We also examined genes involved in iron homeostasis. Iron is a required element for cellular proliferation (Bergeron, 1986) . Since prenatal development is characterized by a very high level of cellular proliferation, we hypothesized that genetic variation modulating iron levels alters developmental capacity as evident by associations of ironregulatory gene polymorphisms with birthweight . Among the iron homeostasis-related genes we examined, SNPs in SLC11A2 (NRAMP2), SLC40A1, TMPRSS6, RRM2 and HMOX1 showed differences in their genotype frequencies between male and female newborns. Of these, only HMOX1 has already been shown to affect RPL susceptibility (Denschlag et al., 2004) . The short (S) alleles (consisting of ≤27 GT repeats) of the microsatellite locus are associated with risk of RPL in women (Denschlag et al., 2004) . This group of microsatellite alleles corresponds to the variant allele A of rs2071748, which show a deficit in newborn males. Thus, the second of the two polymorphisms in our panel that has previously shown associations with RPL yielded expected genotype frequency differences in newborns. The IL6 rs1800796 variant allele is protective from RPL in women (Saijo et al., 2004) and had increased frequency in newborn males whereas the HMOX1 promoter microsatellite S alleles confer increased risk for RPL (Denschlag et al., 2004) and the corresponding SNP genotype had decreased frequency in male newborns. One of the SNPs that were retained in the final set of markers was the IFNG SNP rs2069727 is known to have differential gene expression levels in males and females (Kantarci et al., 2008) . The correlations between previous findings and our observations in newborns are encouraging and suggest plausibility of sex effect in prenatal loss.
In this pilot study, we used a candidate gene approach for selected groups of genes plausibly involved in embryonic development and materno-fetal interactions. The positive results included certain SNPs (HLA-DQA1, HSPA1B) that had to be genotyped manually because of the presence of similar genes in the genome. Such SNPs are not included in microarrays used in genome-wide association studies (GWAS). A GWAS would obviously unravel many more unsuspected associations including those in thrombophilic pathway genes (ESHRE Capri Workshop Group, 2008) but would also miss some associations. Still, a GWAS on a much larger newborn cohort consisting of multiple ethnicities would yield more conclusive results as long as complemented by a candidate gene study using a more gene-oriented approach.
Our study was a relatively small preliminary study. Some of the observed associations could be chance findings. Besides the sample size, another limitation of the present study was the retrospective inference in the interpretation of the results. Any difference observed between male and female newborns may be due to several possibilities. We interpreted such differences as an indication of selection. Although this is a reasonable interpretation, it has to be confirmed in prospective studies. An alternative explanation that can be tested is that these genotypes may cause non-lethal conditions (like high birthweight) and babies with these genotypes may be delivered via Cesarean section and would be missing among the babies born via vaginal delivery. Future prospective studies which include parents as well as offspring and adjust for at least maternal reproductive history characteristics, birth order and sex of previous births should provide more information on whether these polymorphisms are involved in prenatal selection or alternative explanations exist to account for our findings.
Despite previously reported associations, there are no genetic polymorphisms used for prediction of fetal survival in practice. Given the psychosocial and economic burden of reproductive failure and its treatment (Fidler and Bernstein, 1999; Schmidt, 2007) , especially regarding assisted reproductive technologies, any marker that can be used to predict the success of subsequent pregnancies must be useful. Efforts continue to find the best embryo screening test to increase the success rates in assisted fertilization programs (Hillier, 2008) . We do not suggest any clinical application for the provisional associations reported in the present study. It is unlikely that any single genetic marker will be of any use in conditions with complex etiology. It may, however, be feasible to have a strong enough predictive value by combining multiple markers after further validation. Our work represents a proof of principle study and should encourage further studies using the same principle.
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